Back

The DPP4 inhibitor linagliptin exacerbated heart failure due to energy deficiency via downregulation of glucose absorption and utilization in mice.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Anti-diabetic pharmacotherapy in clinical practice Antidiabetic Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Aya Shiraki

Saga University, Saga (Japan)

5 More presentations in this session

Presentation thumbnail
Empagliflozin rescues primary murine cardiac fibroblasts, but not cardiomyocytes, from hypoxia-reoxygenation injury through STAT3-mediated cascades.
Mrs P. Nikolaou (Athens, GR)
Abstract Slides
Presentation thumbnail
Anti-inflammatory potential of SGLT2 inhibitors: a systematic review and meta-analysis of preclinical studies in rodents
Doctor M. Sagris (Athens, GR)
Abstract Slides
Presentation thumbnail
Four-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials in type 2 diabetes: a meta-analysis of individual patient data
Mr G. Wolff (Ibbenbüren, DE)
Abstract Slides
Presentation thumbnail
Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
Doctor M. Elmegaard (Copenhagen, DK) Doctor A. Falkentoft (Roskilde, DK)
Abstract Slides

Access the full session

Session thumbnail
Anti-diabetic pharmacotherapy in clinical practice

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Hypertension and glucose
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources